{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:13:04Z","timestamp":1793815984789,"version":"4.6.1"},"reference-count":55,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>The aim of the study was to evaluate the cost-effectiveness of PET\/CT in the initial N-staging of head\u2013neck cancer (HNC) and to compare it with alternative strategies using CT or MRI within the Greek National Healthcare System. A cohort of 100 clinically N0 (with no apparent metastatic cervical lymph nodes) HNC patients was simulated over a 10-year time horizon. Initially, a decision tree model was used to simulate the following three different imaging strategies for HNC staging: (a) whole-body FDG-PET\/CT, (b) CT of the neck, chest, and abdomen (\u201cCT\u201d), and (c) MRI of the neck plus CT of the chest\u2013abdomen (\u201cMRI\u201d). Subsequently, a Markov model was used to simulate transitions into the health states of recurrence and death. Epidemiological evidence, diagnostic accuracy rates, transition probabilities, and healthcare costs were obtained from the literature and official local tariffs. The estimated total costs per patient were EUR 128,729 for PET\/CT, EUR 128,779 for MRI, and EUR 128,585 for CT. The corresponding life years (LYs) were 6.171 LYs for PET\/CT, 6.170 LYs for MRI, and 6.170 LYs for CT, respectively. The analysis showed that PET\/CT dominates MRI. The incremental cost-effectiveness ratio (ICER) of PET\/CT vs. CT was estimated at EUR 144,984 per LY gained. All three imaging strategies had comparable health outcomes and costs, with PET\/CT being an appropriate and efficient imaging modality because of its high diagnostic accuracy in the N-staging of HNC.<\/jats:p>","DOI":"10.3390\/curroncol32120677","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T17:35:17Z","timestamp":1764956117000},"page":"677","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cost-Effectiveness of Positron Emission Tomography\/Computed Tomography (PET\/CT) in the Initial N-Staging of Head\u2013Neck Cancer and Comparison with CT and Magnetic Resonance Imaging (MRI)"],"prefix":"10.3390","volume":"32","author":[{"given":"Nikolaos","family":"Papathanasiou","sequence":"first","affiliation":[{"name":"Nuclear Medicine Department, University Hospital of Patras, University of Patras, Rio, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Spiliotopoulou","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, University Hospital of Patras, University of Patras, Rio, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Karagkouni","sequence":"additional","affiliation":[{"name":"Radiology Department, University Hospital of Patras, University of Patras, Rio, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Apostolopoulos","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, University Hospital of Patras, University of Patras, Rio, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Katsakiori","sequence":"additional","affiliation":[{"name":"3DMI Research Group, Department of Medical Physics, School of Medicine, University of Patras, Rio, 26504 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Yfantopoulos","sequence":"additional","affiliation":[{"name":"Department of Economics, National and Kapodistrian University of Athens, 15772 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Kotsopoulos","sequence":"additional","affiliation":[{"name":"Department of Economics, National and Kapodistrian University of Athens, 15772 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: Version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/cncr.28860","article-title":"PET\/CT imaging in cancer: Current applications and future directions","volume":"120","author":"Farwell","year":"2014","journal-title":"Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"011013","DOI":"10.1117\/1.JMI.4.1.011013","article-title":"History and future technical innovation in positron emission tomography","volume":"4","author":"Jones","year":"2017","journal-title":"J. Med. Imaging"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1053\/j.sult.2008.05.006","article-title":"Combined positron emission tomography-computed tomography: The historical perspective","volume":"29","author":"Townsend","year":"2008","journal-title":"Semin. Ultrasound CT MRI"},{"key":"ref_5","first-page":"1367","article-title":"A rotating PET scanner using BGO block detectors: Design, performance and applications","volume":"34","author":"Townsend","year":"1993","journal-title":"J. Nucl. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0256-4947.75771","article-title":"18F-FDG PET\/CT imaging in oncology","volume":"31","author":"Almuhaideb","year":"2011","journal-title":"Ann. Saudi Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jamaoncol.2023.0265","article-title":"FDG PET Scans in Cancer Care","volume":"9","author":"Litt","year":"2023","journal-title":"JAMA Oncol."},{"key":"ref_8","unstructured":"National Comprehensive Cancer Network (2023, August 20). Head and Neck Cancers (Version 2.2023). Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2214\/AJR.17.18301","article-title":"Clinical Practice in PET\/CT for the Management of Head and Neck Squamous Cell Cancer","volume":"209","author":"Goel","year":"2017","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.oraloncology.2011.05.011","article-title":"The value of 18F-FDG PET\/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma","volume":"47","author":"Haerle","year":"2011","journal-title":"Oral Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cpet.2019.08.010","article-title":"Diagnosis, Staging, Radiation Treatment Response Assessment, and Outcome Prognostication of Head and Neck Cancers Using PET Imaging: A Systematic Review","volume":"15","author":"Hohenstein","year":"2020","journal-title":"PET Clin."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1097\/RLU.0000000000002247","article-title":"Update 2018: 18F-FDG PET\/CT and PET\/MRI in Head and Neck Cancer","volume":"43","author":"Sanli","year":"2018","journal-title":"Clin. Nucl. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Caldarella, C., De Risi, M., Massaccesi, M., Micciche, F., Bussu, F., Galli, J., Rufini, V., and Leccisotti, L. (2024). Role of 18F-FDG PET\/CT in Head and Neck Squamous Cell Carcinoma: Current Evidence and Innovative Applications. Cancers, 16.","DOI":"10.3390\/cancers16101905"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.14639\/0392-100X-suppl.1-40-2020","article-title":"Metastatic disease in head & neck oncology","volume":"40","author":"Pisani","year":"2020","journal-title":"Acta Otorhinolaryngol. Ital."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.otot.2024.08.009","article-title":"Levels of the neck and classification of neck dissection and incisions","volume":"35","author":"Sciscent","year":"2024","journal-title":"Oper. Tech. Otolaryngol.-Head Neck Surg."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Guedj, D., Neveu, S., Becker, M., and Mermod, M. (2024). FDG PET-CT for the Detection of Occult Nodal Metastases in Head and Neck Cancer: A Systematic Review and Meta-Analysis. Cancers, 16.","DOI":"10.3390\/cancers16172954"},{"key":"ref_17","first-page":"29","article-title":"Cost-effectiveness analysis in radiology: Methods, results and implications","volume":"194","author":"Froelich","year":"2022","journal-title":"R\u00f6Fo"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1001\/jama.2018.2856","article-title":"Adding Cost-effectiveness to Define Low-Value Care","volume":"319","author":"Pandya","year":"2018","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Felder, S., and Mayrhofer, T. (2017). Medical Decision Making\u2014A Health Economic Primer, Springer.","DOI":"10.1007\/978-3-662-53432-8"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Rautenberg, T., Gerritsen, A., and Downes, M. (2020). Health Economic Decision Tree Models of Diagnostics for Dummies: A Pictorial Primer. Diagnostics, 10.","DOI":"10.3390\/diagnostics10030158"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0272989X9301300409","article-title":"Markov models in medical decision making: A practical guide","volume":"13","author":"Sonnenberg","year":"1993","journal-title":"Med. Decis. Mak."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/0272989X211045070","article-title":"Generating, Presenting, and Interpreting Cost-Effectiveness Results in the Context of Uncertainty: A Tutorial for Deeper Knowledge and Better Practice","volume":"42","author":"Bilcke","year":"2022","journal-title":"Med. Decis. Mak."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1007\/s00259-022-05843-4","article-title":"Comparison of CT, MRI, and F-18 FDG PET\/CT for initial N-staging of oral squamous cell carcinoma: A cost-effectiveness analysis","volume":"49","author":"Burian","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/0272989X08315241","article-title":"The half-cycle correction explained: Two alternative pedagogical approaches","volume":"28","author":"Naimark","year":"2008","journal-title":"Med. Decis. Mak."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1056\/NEJMoa1506007","article-title":"Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer","volume":"373","author":"Vaish","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1200\/JCO.18.01182","article-title":"Multicenter Trial of [18F]fluorodeoxyglucose Positron Emission Tomography\/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685","volume":"37","author":"Lowe","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.semnuclmed.2020.07.009","article-title":"PET\/CT in Surgical Planning for Head and Neck Cancer","volume":"51","author":"Strohl","year":"2021","journal-title":"Semin. Nucl. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e217083","DOI":"10.1001\/jamanetworkopen.2021.7083","article-title":"Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic\/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity","volume":"4","author":"Linz","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_29","unstructured":"European Health & Life Expectancy Information System (2023, August 30). Life Tables. Available online: http:\/\/www.eurohex.eu\/IS\/web\/app.php\/Ehleis\/LifeGeographic?Typ=Life&SubTyp=None."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/europace\/eur188","article-title":"Cost effectiveness of cardiac resynchronization therapy in Greece: An analysis based on the CArdiac REsychronization in Heart Failure trial","volume":"13","author":"Maniadakis","year":"2011","journal-title":"Europace"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.6004\/jnccn.2022.0016","article-title":"NCCN Guidelines\u00ae Insights: Head and Neck Cancers, Version 1.2022","volume":"20","author":"Caudell","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zavras, A., Andreopoulos, N., Katsikeris, N., Zavras, D., Cartsos, V., and Vamvakidis, A. (2002). Oral cancer treatment costs in Greece and the effect of advanced disease. BMC Public Health, 2.","DOI":"10.1186\/1471-2458-2-12"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2217\/cer-2020-0167","article-title":"End-of-life cost for lung cancer patients in Greece: A hospital-based retrospective study","volume":"10","author":"Kokkotou","year":"2021","journal-title":"J. Comp. Eff. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"100882","DOI":"10.1016\/j.hlpt.2024.100882","article-title":"Estimating a cost-effectiveness threshold for healthcare decision-making in the Greek NHS","volume":"13","author":"Athanasakis","year":"2024","journal-title":"Health Policy Technol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jval.2016.02.020","article-title":"On the Estimation of the Cost-Effectiveness Threshold: Why, What, How?","volume":"19","author":"Castilla","year":"2016","journal-title":"Value Health"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2217\/cer.15.38","article-title":"Systematic overview of cost-effectiveness thresholds in ten countries across four continents","volume":"4","author":"Schwarzer","year":"2015","journal-title":"J. Comp. Eff. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.vhri.2023.02.006","article-title":"Does a Standard Cost-Effectiveness Threshold Exist? The Case of Greece","volume":"36","author":"Tzanetakos","year":"2023","journal-title":"Value Health Reg. Issues"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2165\/00019053-200826090-00004","article-title":"The NICE cost-effectiveness threshold: What it is and what that means","volume":"26","author":"McCabe","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s40258-023-00803-x","article-title":"A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany","volume":"21","author":"Gandjour","year":"2023","journal-title":"Appl. Health Econ. Health Policy"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/wjnm.WJNM_91_19","article-title":"Precision Radiotherapy: 18F-FDG PET-based radiotherapy planning in Head and Neck cancers","volume":"19","author":"Subramanyam","year":"2020","journal-title":"World J. Nucl. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa1514493","article-title":"PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer","volume":"374","author":"Mehanna","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1002\/cncr.20687","article-title":"The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor","volume":"101","author":"Rusthoven","year":"2004","journal-title":"Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejca.2017.07.054","article-title":"Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer","volume":"85","author":"Smith","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Greuter, M.J., Schouten, C.S., Castelijns, J.A., de Graaf, P., Comans, E.F., Hoekstra, O.S., de Bree, R., and Coupe, V.M. (2017). Cost-effectiveness of response evaluation after chemoradiation in patients with advanced oropharyngeal cancer using 18F-FDG-PET-CT and\/or diffusion-weighted MRI. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3254-0"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Polyzos, N., Karakolias, S., Dikeos, C., Theodorou, M., Kastanioti, C., Mama, K., Polizoidis, P., Skamnakis, C., Tsairidis, C., and Thireos, E. (2014). The introduction of Greek Central Health Fund: Has the reform met its goal in the sector of Primary Health Care or is there a new model needed?. BMC Health Serv. Res., 14.","DOI":"10.1186\/s12913-014-0583-4"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/hpm.3679","article-title":"Exploring the impact of clawback on pharmaceutical expenditure: A case study of public hospitals in Greece","volume":"38","author":"Letsios","year":"2023","journal-title":"Int. J. Health Plan. Manag."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e794","DOI":"10.1016\/S2468-2667(25)00188-4","article-title":"Addressing public health and health system challenges in Greece: Reform priorities in a changing landscape","volume":"10","author":"Kyriopoulos","year":"2025","journal-title":"Lancet Public Health"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Saini, K.S., Somara, S., Ko, H.C., Thatai, P., Quintana, A., Wallen, Z.D., Green, M.F., Mehrotra, R., McGuigan, S., and Pang, L. (2024). Biomarkers in head and neck squamous cell carcinoma: Unraveling the path to precision immunotherapy. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1473706"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mric.2017.08.003","article-title":"PET-Computed Tomography in Head and Neck Cancer: Current Evidence and Future Directions","volume":"26","author":"Chen","year":"2018","journal-title":"Magn. Reson. Imaging Clin. N. Am."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Zschaeck, S., Weingartner, J., Lombardo, E., Marschner, S., Hajiyianni, M., Beck, M., Zips, D., Li, Y., Lin, Q., and Amthauer, H. (2022). 18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.870319"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/JOP.2016.011460","article-title":"Using Quality-Adjusted Life-Years in Cost-Effectiveness Analyses: Do Not Throw Out the Baby or the Bathwater","volume":"12","author":"Goldstein","year":"2016","journal-title":"J. Oncol. Pract."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1524-4733.2004.71246.x","article-title":"Cost-effectiveness versus cost-utility analysis of interventions for cancer: Does adjusting for health-related quality of life really matter?","volume":"7","author":"Tengs","year":"2004","journal-title":"Value Health"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Liao, L.J., Hsu, W.L., Lo, W.C., Cheng, P.W., Shueng, P.W., and Hsieh, C.H. (2019). Health-related quality of life and utility in head and neck cancer survivors. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5614-4"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jamaoto.2015.1314","article-title":"Comparison of Health State Utility Measures in Patients With Head and Neck Cancer","volume":"141","author":"Noel","year":"2015","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jamaoto.2025.0160","article-title":"Development, Validation, and Valuation of a Head and Neck Cancer-Specific Health Utility Instrument (HNC-8D): A Head and Neck Cancer International Group Collaborative Study","volume":"151","author":"Su","year":"2025","journal-title":"JAMA Otolaryngol. Head Neck Surg."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/12\/677\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T18:20:10Z","timestamp":1764958810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/12\/677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":55,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["curroncol32120677"],"URL":"https:\/\/doi.org\/10.3390\/curroncol32120677","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}